Among these biomarkers, elevated cTnI and BNP/NT‐proBNP levels were shown to be associated with increased mortality of cancer patients and to predict the occurrence of ICI‐associated cardiotoxicities, including myocarditis.34 This evidence concerns the gene NPPB and cancer.